Venetoclax 1257044-40-8

ʻO ka wehewehe pōkole:

Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)
Venetoclax 1257044-40-8 CLL Abbvie Jun.27,2031


Huahana Huahana

Huahana Huahana

NUI HUA

维奈妥拉 Venetoclax 1257044-40-8 I-Hale
VCL-6A 98549-88-3 I-Hale
VCL-7A 1235865-75-4 I-Hale
VCLM2 1228780-72-0 I-Hale
VCLM2-2HCl 1628047-87-9 I-Hale
VCLM3 1228779-96-1 I-Hale

Ginoa inoa:venetoclax (ven ET oh klax)
Kapa inoa: ʻO Venclexta, Venclexta Hoʻomaka Pack

Hoʻohana ʻia ʻo Venetoclax e mālama i ka maʻi maʻi lymphocytic maʻi a i ʻole leukemia lymphocytic liʻiliʻi i nā pākeke.Hoʻohana wale ʻia ʻo Venetoclax a i hui pū ʻia me nā lāʻau lapaʻau ʻē aʻe e mālama i kēia mau maʻi.

Hoʻohana ʻia ʻo Venetoclax me ka azacitidine, decitabine, a i ʻole cytarabine e mālama i ka maʻi leukemia myeloid acute.Hoʻohana ʻia kēia hui ʻana i nā pākeke nona nā makahiki 75 a ʻoi paha, a i ʻole hiki ke hoʻohana i ka chemotherapy maʻamau ma muli o nā kūlana olakino ʻē aʻe.

Hāʻawi ʻia ʻo Venetoclax i kekahi manawa ma hope o ka pau ʻole o nā lāʻau lapaʻau ʻē aʻe.

Hiki ke hoʻohana ʻia ʻo Venetoclax no nā kumu i helu ʻole ʻia ma kēia alakaʻi lāʻau lapaʻau.

wehewehe

ʻO Venetoclax (ABT-199; GDC-0199) he mea hoʻopaneʻe Bcl-2 hiki ke koho a me ka haʻi waha me ka Ki o lalo o 0.01 nM.Hoʻokomo ʻo Venetoclax i ka autophagy.

In Vitro

Venetoclax (ABT-199) potently pepehi FL5.12-BCL-2 cell (EC50=4 nM), Venetoclax (ABT-199) hōʻike i ka hana nāwaliwali loa e kū'ē i nā pūnaewele FL5.12-BCL-XL (EC50=261 nM).Hōʻike pū ʻia ʻo ABT-199 i ke koho ʻana i nā hoʻāʻo ʻelua-hybrid cellular mammalian, kahi e hoʻopau ai i nā paʻakikī BCL-2-BIM (EC50=3 nM) akā ʻoi aku ka liʻiliʻi o ka maikaʻi i ka BCL-XL-BCL-XS (EC50=2.2μM) a i ʻole MCL-1-NOXA paʻakikī.

Ma hope o ka nui o ka waha o 12.5 mg no ke kaumaha o ke kino i nā xenografts i loaʻa mai RS4; 11 cell (ALL), ʻo Venetoclax (ABT-199) ke kumu o ka hōʻemi ʻana i ka ulu ulu ʻana (TGImax) o 47% (P<0.001) a me ka ulu ʻana o ka tumor. lohi (TGD) o 26% (P<0.05)[1].

ʻO ka lapaʻau ʻana i ka xenografted i hoʻokumu ʻia (he kumu hoʻohālike ʻiole xenograft o ka T-ALL cell line LOUCY) nā maʻi maʻi me Venetoclax (ABT-199) 100 mg/kg no nā lā 4 e hopena i kahi hōʻemi nui o ke kaumaha leukemic.

Waihona

Pauda

-20°C

3 makahiki

4°C

2 makahiki
I ka solvent

-80°C

6 mahina

-20°C

1 mahina

ʻO ke kinona

Venetoclax 1257044-40-8

HOOLAHA ANOAI

Quality management1

Manaʻo18Nā papahana Loiloi Kūlike Kūlike i ʻae ʻia4, a6nā papahana ma lalo o ka ʻae ʻia.

Quality management2

Ua hoʻokumu ka ʻōnaehana hoʻokele maikaʻi honua kiʻekiʻe i ke kumu kūʻai.

Quality management3

Holo ka nānā ʻana i ka maikaʻi ma ke ola holoʻokoʻa o ka huahana e hōʻoia i ka maikaʻi a me ka hopena therapeutic.

Quality management4

Kākoʻo ka hui ʻoihana Regulatory Affairs i nā koi maikaʻi i ka wā o ke noi a me ke kau inoa ʻana.

HOOLAHA HANA

cpf5
cpf6

Kolea Countec Bottled Packaging Line

cpf7
cpf8

ʻO Taiwan CVC Bottled Packaging Line

cpf9
cpf10

ʻO Italia CAM Board Packaging Line

cpf11

Mekini Fette Compacting German

cpf12

ʻO Iapana Viswill Tablet ʻIke

cpf14-1

Keena Mana DCS

HOA

Ka launa pū ʻana o ka honua
International cooperation
ʻO ka launa pū ʻana o ka hale
Domestic cooperation

  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou